205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.54%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.90%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-38.53%
Negative EBIT growth while QRVO is at 810.08%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-38.53%
Negative operating income growth while QRVO is at 6.61%. Joel Greenblatt would press for urgent turnaround measures.
-413.30%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-427.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-427.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-4.63%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.63%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.93%
Dividend growth of 3.93% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
31.68%
Positive OCF growth while QRVO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
71.62%
Positive FCF growth while QRVO is negative. John Neff would see a strong competitive edge in net cash generation.
-5.13%
Negative 10Y revenue/share CAGR while QRVO stands at 95.48%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-15.47%
Negative 5Y CAGR while QRVO stands at 27.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-15.91%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
85.67%
10Y OCF/share CAGR at 75-90% of QRVO's 108.03%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
50.12%
5Y OCF/share CAGR above 1.5x QRVO's 5.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-19.16%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-771.93%
Negative 10Y net income/share CAGR while QRVO is at 1921.69%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-97.66%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-236.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
384.28%
Positive growth while QRVO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
73.59%
Positive 5Y equity/share CAGR while QRVO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
22.61%
Positive short-term equity growth while QRVO is negative. John Neff sees a strong advantage in near-term net worth buildup.
31.76%
Dividend/share CAGR of 31.76% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
1.27%
Stable or rising mid-term dividends while QRVO is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
11.94%
3Y dividend/share CAGR of 11.94% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-19.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.01%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.48%
Negative asset growth while QRVO invests at 1.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.47%
Under 50% of QRVO's 3.14%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.80%
We cut SG&A while QRVO invests at 19.11%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.